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Abstract
Background: People with diabetes have almost twice the risk of developing cognitive impairment or dementia as
do those without diabetes, and about half of older adults with diabetes will become functionally disabled or cognitively
impaired. But diabetes requires complex self-management: patients must learn about the implications of their disease;
manage their diets, physical activity, and medication; and monitor their blood glucose. Difficulties with cognition can
hinder these activities.
Methods: The purpose of this study was to explore perceptions of cognitive ability in a multiethnic sample of persons
with type 2 diabetes (T2DM). One hundred twenty participants completed surveys assessing perceived memory,
executive function, diabetes self-management, and quality of life. Scores on the surveys were examined along with
hemoglobin A1C levels and demographics.
Results: Scores for executive function were positively associated with self-reports of dietary adherence and blood glucose
monitoring. Perceived memory ability was a significant predictor of quality of life, and executive function was a significant
predictor of A1C.
Conclusions: Patients’ perceptions of their cognitive difficulties may assist health care providers in detection of patients’
deficiencies in performing diabetes self-management tasks. The relationships between cognitive difficulties and self-
management found in this descriptive study suggest that research on the processes leading to cognitive changes in
T2DM is needed, as are studies on how those processes affect diabetes self-management.
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Background
Diabetes is a known risk factor for cognitive impairment,
owing to mechanisms such as chronic hyperglycemia or
hypoglycemia, insulin resistance or hyperinsulinemia,
oxidative stress, and build-up of beta-amyloid protein in
the brain [1]. People with type 2 diabetes (T2DM) have
cognitive impairment at rates that are twice as high as
those for people without T2DM and having diabetes in
midlife is associated with an almost 20% greater decline
in cognitive function over 20 years then for those with-
out T2DM [2]. In addition, some studies have found
changes in brain structure and brain activation patterns
with obesity, insulin resistance, and/or metabolic
syndrome before development of overt T2DM [2]. It is
often assumed that informing a patient about diabetes
self-management skills, including diet, self-monitoring
of blood glucose, and medication management, will
positively influence glycemic control. Yet it is possible
that when patients feel they are experiencing cognitive
problems it will affect all these tasks, and little has been
done to examine the combined effects of diabetes and cog-
nitive impairment on diabetes self-management—especially
in minority groups with a higher prevalence of T2DM and
a higher disease burden [3, 4]. Recent examinations of
cognitive function and diabetes self-management have been
done with small, mostly non-Hispanic white samples,
demonstrating a gap in our understanding of diabetes and
cognitive function and how diabetes is associated with
impairment in specific cognitive domains such as memory
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and executive function in minority groups [5, 6]. The pur-
pose of this study is to examine the relationships between
perceived cognitive function, diabetes self-management,
quality of life, and glycemic control in a multiethnic sample.
Methods
Design, study population, and data collection
This was a cross-sectional, descriptive correlational
study. Over a 5-month period, a convenience sample of
participants from 21 to 70 years old with T2DM was
recruited from an endocrinology clinic in close proxim-
ity to the authors’ university. Recruiting efforts included
the placement of flyers in the clinic’s exam rooms and
research office as well as face-to-face contact by the PI
with potential participants. Potential participants who
expressed interest in the study were screened for eligibil-
ity by the PI and a member of the clinic’s research staff
by asking potential participants questions based on the
inclusion/exclusion criteria. Inclusion criteria were as
follows: ages from 21 to 70; living with diabetes for at
least 1 year; ability to read, speak, and understand
English. Because survey responses from participants with
dementia can be unreliable, those previously diagnosed
with dementia were excluded as well. Patients with
hypertension and hyperlipidemia were included. Those
with type 1 diabetes or who did not know what type they
had were also excluded.
One hundred and eighty-five potential participants
were screened. After the inclusion/exclusion criteria
were applied, 135 patients remained. These participants
received paper copies of the study’s survey instruments
as well as an addressed/stamped envelope to return the
surveys to the primary investigator. They were advised
that return of their questionnaires to the primary inves-
tigator signified informed consent. Of them, 122
returned surveys. Two patients who returned the survey
were excluded because they indicated that they had been
diagnosed with cognitive impairment (Alzheimer’s dis-
ease and impairment after a stroke) when asked to list
other co-morbidities; the final sample included 120 par-
ticipating patients.
Measures
The following survey instruments were used.
Perceived memory
The 57-item Multifactorial Memory Questionnaire
(MMQ) assesses three dimensions of memory self-
appraisal: contentment (feelings about one’s memory),
ability (subjective impressions of one’s memory capabil-
ity), and strategy (reported frequency of use of various
memory aids) [7]. The 18 items for contentment are
rated on a 5-point scale (0 = strongly agree, 1 = agree, 2
= undecided, 3 = disagree, 4 = strongly disagree), with
higher scores suggesting higher contentment about mem-
ory ability. Scores range from 0 to 72, with Cronbach’s
alpha = 0.95 [7]. For ability, 20 items ask participants to
indicate how often specific memory failures have occurred
in the past 2 weeks on a 5-point scale (0 = all the time, 1 =
often, 2 = sometimes, 3 = rarely, 4 = never). Higher scores
reflect better subjective memory ability, with a score range
of 0–80 and a Cronbach’s alpha of 0.93. For strategy, 19
items ask participants to rate how often they use certain
memory strategies (0 = never, 1 = rarely, 2 = sometimes, 3 =
often, 4 = all the time). Scores range from 0 to 76, with
alpha = 0.83 [7].
Perceived executive function
The Barkley Deficits in Executive Function Scale–Short
Form (BDEFS-SF) is used to evaluate executive function
in adults ages 18–81 [8]. The instrument shows the
types and extent of perceived executive function deficits
in daily activities over an extended period of time [8].
Items on the self-report version assess how often partici-
pants have engaged in behaviors that represent specific
types of executive functioning over the past 6 months:
time management, self-organization/problem-solving,
self-restraint, self-motivation, and self-regulation of
emotion. Items are measured on a 4-point Likert scale
ranging from 1 = never or rarely to 4 = very often. The
short form contains 20 items and requires 4–5 min to
complete. Scores from each subscale are tallied and
added to yield a total score. Percentile ranks are com-
puted from the raw scores and compared with norms
determined by age. Higher percentile rankings within a
subscale represent greater executive functioning deficits
in that particular area. Higher percentile scores from the
total raw score represent general executive functioning
deficits. Internal consistency for the short-form scale is
high, with Cronbach’s alpha = 0.92. Pearson’s r correla-
tions across subscales have been found to range from
0.55 to 0.80; test-retest reliability, from 0.62 to 0.80 in
prior studies [8].
Diabetes self-management adherence
The Summary of Diabetes Self Care Activities (SDSCA)
measures five self-reported activities in diabetes self-
management: self-monitoring of blood glucose, diet,
checking one’s feet, exercise, and smoking habits [9].
Participants answer 25 questions about the number of
days in the last week on which they have performed
specific aspects of diabetes self-management. For ex-
ample, a participant has the choice to select a number, 0
through 7, in answer to the question, “How many of the
last seven days have you checked your blood sugar?”
Scores are calculated for each of the five regimen areas;
higher scores indicate greater participation in self-
management behaviors. Inter-item correlations have
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been found to range from r = 0.20 to r = 0.76 for the
SDSCA subscales; 4-month test-retest reliability ranges
from r = -0.05 to 0.78 in prior studies [9].
Quality of life
The RAND 36-item Short Form Health Survey (RAND
SF-36) was developed as part of a multi-year, multi-site
study designed to explain variations in patient outcomes.
It measures eight health dimensions commonly included
in widely used health surveys: role limitations due to
physical problems, social functioning, physical function-
ing, bodily pain, general mental health, role limitations
due to emotional problems, vitality, and general health
perceptions. It also includes a single item that indicates
perceived change in health [10]. Total scores range from 0
(poorest health) to 100 (best health). The survey’s scales
have been shown to have adequate internal consistency,
with alphas ranging from 0.72 to 0.94 [11]. Test-retest
values ranged from 0.60 to 0.90, with the exception of
bodily pain at 0.43. Factor analysis resulted in two higher
order factors representing the physical and mental health
constructs of the instrument. The subscale of “general
health” was used to indicate quality of life for this project.
Demographics
Participants also completed a short demographic form
that included questions regarding age, ethnicity, A1C
level, educational level, medications, and co-morbidities.
Data analysis
Data were analyzed using the Statistical Package for Social
Sciences, Version 22.0 [12]. Descriptive variables were re-
ported (numbers, percentages, means with standard devia-
tions) for all variables. Pearson’s bivariate correlation
analysis was used to assess correlations between demo-
graphic variables and the survey scores (MMQ, BDEFS-
SF, etc.) and between the survey scores themselves. The
significance level was set at 0.05. Separate multiple linear
regressions were conducted to predict the impact of per-
ceived cognitive function on quality of life and A1C.
Results
Demographic characteristics
Table 1 presents the characteristics of the total sample
(n = 120). Half of the participants were from minority
populations. Participants’ mean reported A1C was 8.6%
(SD = 1.5). The number of co-morbidities ranged from 0
to 4; 75% had hyperlipidemia; 62.2%, hypertension;
15.6%, hypothyroidism. There were no significant differ-
ences in number of co-morbidities between age groups.
Fifty-one percent were on oral glucose-lowering medica-
tions, 31% on insulin, and 17.5% on a combination of
oral medications and insulin. Only 4.2% of the partici-
pants were not on any medications, and 1.6% noted the
type of medication as “other” and wrote it in as an in-
jectable non-insulin such as liraglutide. Results from the
SDSCA show that adherence to diet and exercise was
low, with participants averaging only 3 days a week of
adherence to a healthy diet and less than 2 days a week
of at least 30 min of exercise.
Scores on the subscales of the MMQ and BDEFS-SF
were calculated for all 120 participants (Table 2). MMQ
ability and contentment scores fell in the middle range,
indicating moderate subjective memory ability but mod-
erate contentment with overall memory. Use of compen-
satory memory strategies (e.g., list making, reminders,
etc.) was low. Scores on the BDEFS-SF were compared
with a normative population and ranged from marginal
clinical significance (76th–84th percentile) to markedly
deficient (99th percentile) [8]. The mean score for the
total BDEFS-SF placed these participants in the 94th
percentile (mildly deficient). No significant differences
were seen in scores between ethnic groups.
Pearson’s bivariate correlations (see Table 2) demon-
strated a weak but significant positive correlation be-
tween age and self-organization on the BDEFS-SF (r
= .26, p < 0.01) as well as between education and both
BDEFS-SF self-motivation and total BDEFS-SF (r = .26,
p < 0.01; r = .19, p < 0.05). Length of time with diabetes
was positively correlated with decreased levels of self-
restraint (r = .20, p < 0.05). Moderate significant correla-
tions were found between A1C and some of the BDEFS-
SF subscale scores (range, r = .32 to .46, p < 0.01). Total
BDEFS-SF scores were weakly to moderately related to
measures of diabetes self-management (range, r = -.07 to
-.33, p < 0.01), and MMQ scores were weakly associated
with diabetes self-management (Table 3).
Multiple linear regression analyses were conducted to
predict the variation in quality of life and A1C. Variables
significantly related to quality of life were entered simul-
taneously: MMQ ability, MMQ strategies, and BDEFS-
SF total. Results showed that all variables in the model
explained 38% of the perceived quality of life score and
23% of the A1C. Perceived memory ability (MMQ abil-
ity) was the strongest predictor of quality of life (β
= .285, p = 0.004), and total scores on the BDEFS-SF
were the strongest predictors of A1C (β = .445, p < 0.01).
To evaluate glycemic control, the same regression ana-
lysis was run, but A1C replaced the quality of life vari-
ables. The analysis showed that the cognitive variables,
when considered together, also significantly explained
29% of the A1C. The strongest predictor in the model
was the total BDEFS-SF score (β = .62, p = 0.011),
followed by memory contentment (β = -.19, p < 0.05).
Discussion
This study shows a clear relationship between perceived
cognitive function, aspects of diabetes self-management,
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Age (years) 53.7 (3.5) 53.7 (14.0) 53.5 (12.7) 52.1 (13.8) 33.0
Gender (% female) 49.2 (n = 59) 40.7 50.0 76.2 100
Education %(n)
High School 15 (18) 14.8 (8) 15.9 (7) 9.5 (2) 100 (1)
Some College 15 (18) 14.8 (8) 18.2 (8) 9.5 (2)
Associates 16.7 (20) 14.8 (8) 18.2 (8) 19.0 (4)
College Graduate 36.8 (44) 35.2 (19) 34.1 (15) 47.6 (10)
Master’s Degree 8 (10) 9.3 (5) 6.8 (3) 9.5 (2)
Doctoral Degree 8 (10) 11.1 (6) 6.8 (3) 4.8 (1)
Diabetes duration (years) 6.7 (5.1) 6.4 (4.6) 7.0 (5.2) 7.4 (6.0) 1.0
A1C 8.6 (1.5) 8.6 (1.5) 8.8 (1.6) 8.1 (1.3) 6.0
Number of co-morbidities 1.3 (1.03)
range = 0 to 4
1.3 (0.99)
range = 1 to 3
1.4 (1.06)
range = 1 to 4
1.2 (1.0)
range = 1 to 3
0
Days per week of diet adherence 3.28 (1.29) 3.35 (1.27) 3.35 (1.36) 3.00 (1.23) 2.50
Days per week of exercise adherence 1.37 (1.39) 1.31 (1.22) 1.42 (1.54) 1.52 (1.53) 0
Days per week of glucose monitoring 2.76 (2.17) 2.76 (2.20) 2.82 (2.14) 2.40 (1.92) 7
Days per week of foot care 1.79 (1.33) 1.72 (1.30) 1.76 (1.40) 2.11 (1.28) 0
MMQ contentment 34.5 (5.2) 34.5 (5.5) 34.7 (5.0) 33.2 (4.8) 42.0
MMQ ability 40.1 (7.4) 40.0 (7.3) 41.2 (7.6) 38.4 (7.6) 39.0
MMQ strategies 28.5 (7.5) 28.8 (7.2) 28.8 (7.5) 27.4 (8.5) 24.0
BDEFS time 10.1 (2.2) 10.0 (2.0) 10.4 (2.2) 9.2 (2.2) 8
BDEFS self-organization 9.6 (2.1) 9.8 (2.2) 9.4 (1.9) 9.2 (1.8) 10
BDEFS self-restraint 8.4 (2.2) 8.2 (2.3) 8.7 (2.2) 8.0 (2.0) 9
BDEFS motivation 8.5 (2.0) 8.6 (1.8) 8.4 (2.1) 8.3 (2.1) 9
BDEFS emotion 9.6 (2.1) 9.7 (1.8) 9.5 (2.6) 9.1 (1.7) 13
BDEFS total 46.2 (6.1) 46.6 (6.2) 46.6 (6.6) 44.0 (4.4) 49.0
Values are Mean (Standard Deviation) unless otherwise noted
Table 2 Correlations between demographic characteristics and
cognitive variables
Age Education A1C Years with DM
MMQ contentment .09 -.07 -.19b -.03
MMQ ability .03 -.04 -.13 -.01
MMQ strategies .07 -.09 -.01 -.05
BDEFS-SF time .04 .09 .32b .02
BDEFS-SF self-organization .26a .10 .12 .04
BDEFS-SF self-restraint .08 .17 .34a .19b
BDEFS-SF self-motivation .03 .26a .37a -.03
BDEFS-SF self-regulation
of emotion
-.01 -.05 .17 -.03
BDEFS-SF total .14 .19b .46a .07
aCorrelation is significant at the 0.01 level
bCorrelation is significant at the 0.05 level





MMQ contentment .09 -.03 -.01 -.02
MMQ ability .25a .23b .00 .16
MMQ strategies .12 -.02 -.10 -.01
BDEFS-SF time -.17 .04 -.09 -.20b
BDEFS-SF self-organization -.26a -.14 -.22b -.10
BDEFS-SF self-restraint -.13 -.08 -.03 .71
BDEFS-SF self-motivation -.22b -.14 -.03 -.26a
BDEFS-SF self-regulation
of emotion
-.17 .10 -.08 .29
BDEFS-SF total -.33a -.07 -.10 -.29a
aCorrelation is significant at the 0.01 level
bCorrelation is significant at the 0.05 level
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and glycemic control. The results also indicate that that
the cognitive function variables examined here are im-
portant for health care providers to bear in mind when
they discuss diabetes self-management with patients.
This is consistent with prior studies that have demon-
strated the importance of screening for executive
dysfunction in people with diabetes, but how changes in
executive function capacity impact self-management
capacity needs more study [13–15].
Participants had some perceived impairment in mem-
ory and executive functioning, as indicated by the scores
on the MMQ and BDEFS-SF. Both scales have been used
to assess perceived memory and executive function in a
number of groups [16, 17]. The MMQ has been tested,
for example, in French (n = 114; mean age, 71.7) and
Dutch (n = 294; mean age, 65.9) elderly non-clinical pop-
ulations [6, 18]. Illman et al. tested it in a sample with
temporal lobe epilepsy along with healthy controls [17].
All three studies found the MMQ valid and reliable. The
present study is one of the first to use the MMQ and
the BDEFS-SF for participants with T2DM. The results
support the idea that people with T2DM have concern
about their memory but use fewer strategies to compen-
sate for their perceived memory difficulties. They also
have lower levels of goal-directed behavior. In studies of
other chronic conditions, people who judge their mem-
ory to be poor have also had difficulty in creating
approaches to solving illness-related problems [19, 20].
Thus, people with diabetes and perceived memory diffi-
culty may also have problems in developing strategies to
deal with self-management issues. Complaints about
memory should be considered by health care providers
as an indicator of a potentially reduced ability to cope
with diabetes problems. Of course there may be other
contributors to the present results apart from diabetes
alone, such as baseline intelligence, baseline brain
volume, and genetic predispositions [21]. Future research
is needed to investigate relationships between these cogni-
tive function variables, objective neuropsychological tests,
and functional MRI imaging.
No significant relationships were found between
ethnicity and cognitive function variables in this
study, but the higher prevalence of T2DM in minority
populations reported in other studies indicates that
the overall prevalence of cognitive dysfunction in
those populations could be greater as well [22, 23]. In
other words, there might still be issues in dealing
with diabetes self-management that are not experi-
enced by non-Hispanic whites. Previous research has
shown a connection between cognition and diabetes
in large populations; but there remain important
differences in diabetes burden, and little is known
about the relationships between diabetes and cogni-
tion in underserved groups [24].
Duration of diabetes has been associated with in-
creased rates of cognitive impairment, with one study
estimating that diabetes duration of greater than 10 years
was linked to at least a 55% greater risk of major cogni-
tive impairment than in people without diabetes [25].
The mean number of years with diabetes for those in
the present study was 6.7 years, with a range of 1 to
24 years; 20% of the sample was in the >10 years cat-
egory for cognitive impairment risk. Additionally, the
number of co-morbidities is connected to an increased
risk for cognitive impairment [25]. All participants
except one in this sample had at least one co-morbidity.
The most frequent co-morbidity was hyperlipidemia,
followed by hypertension, both of which are conditions
with well-established links to cognitive impairment [26].
Given our results and the association of higher A1C
levels with lower perceived executive function, the possibil-
ity of an effect of cognition on diabetes self-management
cannot be excluded. The presence of perceived impairment
in executive function was significantly related to higher
A1C levels. This is consistent with prior studies using
objective, as opposed to self-report, measures of executive
function [15]. The present study’s findings also support
studies in which executive function, measured by objective
neuropsychiatric tests, was related to lower levels of
diabetes self-management [4, 15]. The present findings
demonstrate that self-reports may be valid and useful tools
to screen for cognitive dysfunction, comparable to tools
that require specialized training to administer. Adherence
to a dietary regimen for T2DM requires an individual to
plan meals and be mindful of carbohydrate and calorie
content while remembering other foods consumed that
day. Such attention necessitates the utilization of both
memory and executive function. Detailed data on the
mechanisms of this effect of changes in memory and execu-
tive function on diabetes self-management are generally
absent in current research [27].
Other investigations have shown that changes in
cognitive function predicted diabetes medication adher-
ence irrespective of treatment complexity [28]. The
present results did not indicate a significant association
between medication adherence and the examined cogni-
tive variables. Some studies have examined mechanisms
of the underlying pathology of cognitive impairment and
diabetes such as fluctuations in glucose, but how those
mechanisms might be clinically relevant remains unclear
[5]. Although the present study was not undertaken to
address the causal pathogenesis of cognitive decline, that
topic should receive further investigation.
Both A1C and some of the examined cognitive vari-
ables were predictors of quality of life in this sample.
Trials have shown that adults who engage in aerobic
training show improvements in cognitive areas such as
memory and executive function as well as in quality of
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life [29]. The present sample had low levels of exercise,
and it is possible that interventions to increase physical
activity could have improved their cognitive function,
quality of life, and glycemic control. Other quality of life
factors such as constricted life-space and few hours
spent outside the home are also related to decreasing
levels of cognitive function, but studies examining the
effects of environmental factors affecting quality of life
along with cognition and diabetes self-management have
not been completed [30].
Limitations
The results of this study show a relationship between
perceived cognitive function, specifically executive
function, and diabetes in a multiethnic sample. How-
ever, the study has some limitations. First, the study
relied on self-reported data, which might include
answers influenced by social desirability. In future
studies, researchers might want to add neuropsycho-
logical tests in which participants are observed as
they perform activities for comparison. Using lab-reported
A1C from medical records or blood samples would
also help to prevent this limitation. The small sample
size from a single area of the country also limits
generalizability. But the inclusion of a sample with
over 50% from minority populations is a strength.
Also, because of the study’s cross-sectional design,
only associations were measured; conclusions about
causality could not be made.
Conclusions
Diabetes can affect cognitive function, and cognitive
function may affect diabetes self-management, which is
critical for glycemic control [5, 6]. Guidelines issued in
the past several years have endorsed screening for cogni-
tive impairment in people with diabetes because such
impairment may hinder self-management [31, 32]. The
results of this study suggest clinical implications: cogni-
tive assessment of executive function and memory corre-
lated with glycemic control should be included in
diabetes treatment plans. Poor performance on self-
report assessments for cognitive function can signal
health care providers to ask patients about their
perceived deficiencies in performing self-management
tasks, so that they can develop individualized plans of
care that take patients’ insights and preferences into
account as well as refer patients for more in-depth
neurological evaluations if needed [33]. Research regard-
ing the processes that lead to cognitive changes in
T2DM is needed; so too are studies of how those pro-
cesses affect self-management activities. Finally, longitu-
dinal studies should be conducted to examine the
relationships between cognitive variables and self-
management activities over time.
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